What is the recommended workup for a 3 cm left adrenal nodule with characteristics suggestive of an adenoma on imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a 3 cm Left Adrenal Nodule with Signal Loss on Out-of-Phase Images

For a 3 cm left adrenal nodule demonstrating diffuse intralesional hypointense signal on out-of-phase images relative to in-phase images, biochemical evaluation for hormone excess is recommended, with no further imaging follow-up needed as this represents a benign adenoma. 1

Radiological Interpretation

The imaging findings described in the question are classic for an adrenal adenoma:

  • Signal loss on out-of-phase images compared to in-phase images on MRI is diagnostic of intracellular lipid content
  • This chemical-shift MRI finding is highly specific for benign adrenal adenomas 2, 1
  • The 3 cm size places this nodule in a relatively low-risk category for malignancy 2

Recommended Workup Algorithm

1. Hormonal Evaluation (Required for ALL adrenal nodules)

Even though the imaging characteristics strongly suggest a benign adenoma, all adrenal nodules require hormonal evaluation to rule out subclinical hormone excess 1:

  • Cortisol secretion: 1 mg overnight dexamethasone suppression test (cortisol ≤50 nmol/L or ≤1.8 μg/dL indicates normal suppression) 1, 3
  • Catecholamine excess: Plasma or 24-hour urinary metanephrines to exclude pheochromocytoma 1
  • Aldosterone production: Aldosterone-to-renin ratio if hypertension is present 1

2. Imaging Follow-up

  • No additional imaging is required for this nodule as:
    • The size is less than 4 cm
    • The chemical-shift MRI findings are diagnostic of a lipid-rich adenoma 2, 1
    • The ACR Appropriateness Criteria states that small (<3 cm) incidentally discovered adrenal masses with benign imaging characteristics do not justify extensive and costly workup 2

3. Management Based on Hormonal Evaluation Results

  • If non-functioning: No further follow-up needed 2, 1
  • If hormone-producing:
    • Cortisol excess: Consider adrenalectomy (laparoscopic when feasible) with postoperative corticosteroid supplementation 2
    • Aldosterone excess: Adrenalectomy (laparoscopic preferred) for unilateral aldosterone production 2
    • Catecholamine excess: Surgical resection after appropriate alpha-blockade 1

Important Considerations

  • Size threshold: While this 3 cm nodule falls at the borderline of size criteria, the definitive chemical-shift MRI findings of lipid content strongly support benign etiology 2, 1
  • Subclinical function: Studies have shown that 5-23% of incidentally discovered adrenal masses may have subclinical hormone production despite being asymptomatic 2
  • Malignancy risk: The risk of malignancy for adrenal nodules <4 cm with benign imaging characteristics (like lipid-rich adenomas) is extremely low (approximately 0%) 1

Common Pitfalls to Avoid

  • Unnecessary follow-up imaging for lipid-rich adenomas <4 cm with benign characteristics wastes resources and causes patient anxiety 1
  • Failure to perform hormonal evaluation even for small adenomas can lead to missed diagnosis of subclinical hormone excess 1
  • Performing adrenal biopsy is rarely indicated for adrenal masses with characteristic imaging features of adenoma and should be avoided 1, 4
  • Overlooking the possibility of mild autonomous cortisol secretion (MACS), which can contribute to metabolic complications even without overt Cushing's syndrome 3

This nodule demonstrates classic imaging features of a benign adrenal adenoma, and with appropriate hormonal evaluation, no further imaging follow-up is needed unless hormonal abnormalities are detected.

References

Guideline

Management of Adrenal Nodules

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.